Angene Chemical
Draw
|
Currency :
Home Products

AG007NQ7

129-20-4 | Oxyphenbutazone

Chemical structure of Oxyphenbutazone, CAS 129-20-4
AG007NQ7
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 129-20-4
Catalog Number AG007NQ7(AGN-PC-07Y4TY)
Chemical Name Oxyphenbutazone
EC Number 204-936-2
IUPAC Name 4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione
InChI InChI=1S/C19H20N2O3/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15/h4-8,10-13,17,22H,2-3,9H2,1H3
InChI Key HFHZKZSRXITVMK-UHFFFAOYSA-N
MDL Number MFCD00057278
Molecular Formula C19H20N2O3
Molecular Weight 324.3737
SMILES O=C(C1CCCC)N(C2=CC=CC=C2)N(C3=CC=C(O)C=C3)C1=O
Synonyms
Diflamil, Hydroxyphenylbutazone, Oxyphenbutazone, Oxyphenylbutazone, Tanderil, oxyphenbutazone, Oxyphenylbutazone, Oxifenylbutazon, Oxiphenbutazone, Butapirone, Flamaril, Oxazolidin, Tandearil, Tanderil, Oxyphenobutazone, p-Oxyphenylbutazone, 129-20-4, Oxi-Fenibutol, Artroflog, Butaflogin, Butanova, Butazonic, Butilene, Crovaril, Deflogin, Etrozolidina, Flanaril, Floghene, Flogistin, Flogitolo, Flogodin, Flogoril, Flogostop, Flopirina, Idrobutazina, Infammil, Ipabutona, Isobutazina, Isobutil, Offitril, Oxibutol, Oxybuton, Oxyphentamin, Pirabutina, Piraflogin, Poliflogil, Rapostan, Tandacote, Tandalgesic, Tendearil, Visubutina, Flogal, Frabel, Infamil, Iridil, Mysite, Neofen, Optimal, Oxalid, Remazin, Reumox, Rumapax, Telidal, Valioil, Metabolite I, Neo-Farmadol, Oxazolidin-Geigy, p-Hydroxyphenylbutazone, Californit, Oxiphenbutazonum, Usaf Ge-14, Hydroxyphenylbutazon, Oxifenbutazona, Aradinum, Butanora, Flegmostam, Oxazolioin, Portoril, Reunabutal, Telidac, Genal, Oxyphenbutazonum, Cinophen-N, Tanderal, Ossifenbutazone [DCIT], BM 1, 1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine, 1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione, Oxifenbutazona [INN-Spanish], Oxyphenbutazonum [INN-Latin], Oxyphenbutazone [INN], Oxyphenbutazone anhydrous, 4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione, 4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione, 4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine, 4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione, 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-, Oxyphenyl butazone, CCRIS 6717, 1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-n-butylpyrazolidine, 3,5-Dioxo-1-phenyl-2-(p-hydroxyphenyl)-4-N-butylpyrazolidene, G 27202, HSDB 3144, EINECS 204-936-2, 1-p-Hydroxyphenyl-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine, NSC 526053, BRN 0307474, AI3-26792, MLS003373849, 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl, 3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-, CHEBI:76258, HFHZKZSRXITVMK-UHFFFAOYSA-N, Oxyphenbutazone (INN), 1-(p-Hydroxyphenyl)-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine, AB00052064_08, DSSTox_CID_25291, DSSTox_RID_80784, DSSTox_GSID_45291, metabolite, Ossifenbutazone, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione, Hydroxyphenylbutazone, 4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE, SR-05000001689, metabolitie, Romaxin, Suganril, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-1,2-diazolidine-3,5-dione, NCGC00016389-01, CAS-129-20-4, OPB, Reozon (TN), Oxyphenbutazone (TN), Spectrum_001073, AC1L1IMG, Oxyphenbutazone, Tanderil, Prestwick0_001049, Prestwick1_001049, Prestwick2_001049, Prestwick3_001049, Spectrum2_000153, Spectrum3_000535, Spectrum4_001155, Spectrum5_000998, Oxyphenbutazone (anhydrous), AC1Q6L3L, CHEMBL1228, SCHEMBL25857, BSPBio_000978, BSPBio_002149, KBioGR_001729, KBioSS_001553, labotest-bb lt00134684, DivK1c_000302, SPECTRUM1500455, SPBio_000286, SPBio_002909, BPBio1_001076, DTXSID1045291, CTK8G2232, HMS500P04, KBio1_000302, KBio2_001553, KBio2_004121, KBio2_006689, KBio3_001649, NINDS_000302, BDBM200298, HMS1571A20, HMS1920D20, HMS2091L20, HMS2098A20, HMS2236G07, HMS3373B01, HMS3715A20, Pharmakon1600-01500455, BCP20014, Tox21_110414, CCG-38944, NSC526053, NSC757261, SBB057012, AKOS024362800, Tox21_110414_1, API0006917, DB03585, MCULE-3785704527, NSC-526053, NSC-757261, VZ36732, IDI1_000302, NCGC00094748-01, NCGC00094748-02, NCGC00094748-03, NCGC00094748-04, NCGC00094748-07, (+/-)-Oxyphenbutazone-d9(N-butyl-d9), AN-23036, SBI-0051471.P003, LS-128612, 3, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-, AB00052064, FT-0673468, ST50993915, WLN: T5VNNV EHJ BR DQ & CR & E4, 3, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-, OXYPHENBUTAZONE 4-HYDROXYPHENYLBUTAZONE, C19494, D08324, C-44320, J-005659, SR-05000001689-1, SR-05000001689-3, BRD-A33749298-001-05-0, 1-(p-hydroxyphenyl)-2-phenyl-4-butylpyrazolidine-3,5-dione, 3,5-Pyrazolidinedione,4-butyl-1-(4-hydroxyphenyl)-2-phenyl-, 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl- (9CI), 3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl- (VAN), 3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl- (VAN) (8CI), Diflamil, Oxyphenbutazone-d9, D06ZPS, UNII-A7D84513GV, cid_4641, MLS002154125, C19H20N2O3, CID4641, A7D84513GV, AR-1J3987, C19-H20-N2-O3, CS-O-30713, SMR001233432, 5-24-05-00404 (Beilstein Handbook Reference), D010113, 1189693-23-9, 7081-38-1, 7356-71-0,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited